DarioHealth
DRIO
45 hedge funds and large institutions have $36.4M invested in DarioHealth in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 5 closing their positions.
30% more call options, than puts
Call options by funds: $48K | Put options by funds: $37K
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
0.07% less ownership
Funds ownership: 1.79% → 1.72% (-0.07%)
5% less capital invested
Capital invested by funds: $38.1M → $36.4M (-$1.76M)
2% less funds holding
Funds holding: 46 → 45 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWAM
Appian Way Asset Management
New York
|
+$981K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$212K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$63.5K |
| 4 |
MIM
Marco Investment Management
Atlanta,
Georgia
|
+$36.1K |
| 5 |
Renaissance Technologies
New York
|
+$27.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$1.29M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$187K |
| 3 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$146K |
| 4 |
BlackRock
New York
|
-$138K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$116K |
DRIO Hedge Fund Activity: Q2 2023 in Review
45 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q2 2023, worth a combined $36.4M — down 4.6% from $38.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of DRIO and 4 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 12 added.
The largest buyer was Appian Way Asset Management, adding an estimated $981K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.29M sold.
- 45 institutional investors held DarioHealth (DRIO) as of Q2 2023, down from 46 in Q1 2023.
- Funds reported $36.4M of DarioHealth stock for Q2 2023, down 4.6% quarter-over-quarter.
- 4 funds opened new DarioHealth positions in Q2 2023 and 5 closed out, a net change of -1 holder.
- The largest DarioHealth buyer in Q2 2023 was Appian Way Asset Management, an estimated $981K added.
- The largest DarioHealth seller in Q2 2023 was Perceptive Advisors, an estimated $1.29M sold.
Based on aggregated 13F filings for Q2 2023.